« back

DEBRA International: All Priorities Call

  Tuesday, 06 Apr 2021 | Funding Deadline

The key aim of DEBRA International is to coordinate, in collaboration with its members, activities that are for the benefit of everyone affected by Epidermolysis bullosa (EB) globally: the international patient community, patient support and advocacy groups, healthcare professionals, researchers, and industry.

DEBRA is currently accepting applications for their all priorities call. Current research priorities are:

1. Improving understanding of EB biology to create new concepts for diagnosis and treatment.
2. Developing disease-modifying and curative therapies.
3. Preventing and curing severe disease consequences: chronic wounds, fibrosis, and cancer.
4. Improving clinical care and symptom relief through research.

 

Deadline for proposals: 6th April 2021

Find out more here